PTC Therapeutics PTCT Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Operating margin | 1.6%-38.7pp | 54.2%+91.7pp | 43.6%+59.2pp | 40.7%+63.3pp | 40.2%+80.5pp | |
| Efficiency | ||||||
| Asset turnover | 0.3×-0.5× | 0.8×+0.3× | 0.8×+0.2× | 0.8×+0.2× | 0.8×+0.3× | |
| Liquidity | ||||||
| Current ratio | 2.4×-1.5× | 2.3×0.0× | 2.3×+0.2× | 3.6×+1.4× | 3.9×+1.9× | |
| Leverage | ||||||
| Net debt / EBITDA | -7.3×-5.8× | -0.6×— | -0.3×+12.7× | -0.8×+191× | -1.5×— | |
| Per Share | ||||||
| Book value per share | -$2.19-1.7% | -$2.32+83.7% | -$1.79+87.0% | -$2.64+79.3% | -$2.15+81.6% | |
| Valuation | ||||||
| Market capitalization | $5.64B+40.3% | $6.1B+75.2% | $4.88B+71.3% | $3.93B+68.1% | $4.02B+83.0% | |
| Price / sales | 6.8×+4.6× | 3.5×-0.8× | 2.7×-0.4× | 2.2×-0.4× | 2.3×-0.1× | |
| EV / EBITDA | 86.6×+82.7× | 5.6×— | 5.7×-283× | 4.4×-1,552× | 4×— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are PTC Therapeutics's profit margins?
- PTC Therapeutics (PTCT) runs a 96.0% gross margin and a 1.6% operating margin, with a 42.3% net margin.
- Where do PTC Therapeutics's ratios come from?
- Every ratio is computed from PTC Therapeutics's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
